Pleural mesothelioma incidence in Europe: evidence of some deceleration in the increasing trends.

PubWeight™: 1.32‹?› | Rank: Top 10%

🔗 View Article (PMID 14674744)

Published in Cancer Causes Control on October 01, 2003

Authors

Fabio Montanaro1, Freddie Bray, Valerio Gennaro, Enzo Merler, Jerzy E Tyczynski, Donald Maxwell Parkin, Marija Strnad, Marie Jechov'a, Hans H Storm, Tiiu Aareleid, Timo Hakulinen, Michel Velten, Hacina Lef'evre, Arlette Danzon, Antoine Buemi, Jean-Pierre Daur'es, François Ménégoz, Nicole Raverdy, Martine Sauvage, Hartwig Ziegler, Harry Comber, Eugenio Paci, Marina Vercelli, Vincenzo De Lisi, Rosario Tumino, Roberto Zanetti, Franco Berrino, Giorgio Stanta, Frøydis Langmark, Jadwiga Rachtan, Ryszard Mezyk, Jerzy Blaszczyk, Plesko Ivan, Maja Primic-Zakelj, Alvaro Cañada Martínez, Isabel Izarzugaza, Joan Borràs, Carmen Martínez Garcia, Isabel Garau, Navarro Carmen Sánchez, Ardanaz Aicua, Lotti Barlow, Joachim Torhorst, Christine Bouchardy, Fabio Levi, Thomas Fisch, Nicole Probst, Otto Visser, Mike Quinn, Anna Gavin, David Brewster, Marica Mikov, ENCR Working Group

Author Affiliations

1: Mesothelioma Registry of Liguria, Unit of Environmental Epidemiology and Applied Biostatistics, National Cancer Research Institute (IST), Genova, Italy. fabio.montanaro@ti.ch

Articles by these authors

Global cancer statistics. CA Cancer J Clin (2011) 185.92

Global cancer statistics, 2002. CA Cancer J Clin (2005) 119.22

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer (2010) 90.16

Global cancer statistics, 2012. CA Cancer J Clin (2015) 53.52

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer (2014) 40.30

Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol (2012) 9.28

Effect of screening mammography on breast-cancer mortality in Norway. N Engl J Med (2010) 8.71

International variation in prostate cancer incidence and mortality rates. Eur Urol (2012) 8.04

Chapter 2: The burden of HPV-related cancers. Vaccine (2006) 7.70

Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol (2008) 7.18

Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database. BMJ (2010) 7.00

Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst (2005) 6.69

Lung cancer susceptibility locus at 5p15.33. Nat Genet (2008) 5.99

Geographical patterns and time trends of cancer incidence and survival among children and adolescents in Europe since the 1970s (the ACCISproject): an epidemiological study. Lancet (2004) 5.64

Fruit, vegetables, and olive oil and risk of coronary heart disease in Italian women: the EPICOR Study. Am J Clin Nutr (2010) 5.50

Global burden of human papillomavirus and related diseases. Vaccine (2012) 5.48

Regression models for relative survival. Stat Med (2004) 5.40

Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome. Am J Pathol (2002) 5.20

End-of-life decision-making in six European countries: descriptive study. Lancet (2003) 5.16

Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet (2009) 5.14

Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness. Eur J Cancer (2008) 5.00

Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions. Lancet (2012) 4.76

Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. J Natl Cancer Inst (2007) 4.55

Meat, fish, and colorectal cancer risk: the European Prospective Investigation into cancer and nutrition. J Natl Cancer Inst (2005) 4.45

Cancer mortality in India: a nationally representative survey. Lancet (2012) 4.30

Geographic pathology revisited: development of an atlas of cancer in India. Int J Cancer (2005) 4.22

Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). J Natl Cancer Inst (2006) 4.17

Dietary intervention in infancy and later signs of beta-cell autoimmunity. N Engl J Med (2010) 4.16

Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal, nested case-control study in the Nordic countries. Int J Cancer (2004) 4.10

Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. Int J Cancer (2002) 4.02

Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe. Int J Cancer (2003) 3.89

Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat Genet (2013) 3.81

International lung cancer trends by histologic type: male:female differences diminishing and adenocarcinoma rates rising. Int J Cancer (2005) 3.81

Complete excision of primary breast tumor improves survival of patients with metastatic breast cancer at diagnosis. J Clin Oncol (2006) 3.77

Recent patterns in gastric cancer: a global overview. Int J Cancer (2009) 3.75

Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian Randomized Controlled Trial--SCORE. J Natl Cancer Inst (2011) 3.75

Breast cancer mortality in neighbouring European countries with different levels of screening but similar access to treatment: trend analysis of WHO mortality database. BMJ (2011) 3.74

Evaluation of data quality in the cancer registry: principles and methods Part II. Completeness. Eur J Cancer (2009) 3.67

Flavonoid intake and risk of chronic diseases. Am J Clin Nutr (2002) 3.57

Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study. J Clin Oncol (2002) 3.53

Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): an observational study. Lancet (2003) 3.53

Modified Mediterranean diet and survival: EPIC-elderly prospective cohort study. BMJ (2005) 3.48

Methods for pooling results of epidemiologic studies: the Pooling Project of Prospective Studies of Diet and Cancer. Am J Epidemiol (2006) 3.41

Prediction of cancer incidence in the Nordic countries up to the year 2020. Eur J Cancer Prev (2002) 3.40

Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev (2009) 3.33

Point: myeloperoxidase -463G --> a polymorphism and lung cancer risk. Cancer Epidemiol Biomarkers Prev (2002) 3.33

Short- and long-term mortality with localized prostate cancer. Arch Intern Med (2007) 3.23

The association of pattern of lifetime alcohol use and cause of death in the European prospective investigation into cancer and nutrition (EPIC) study. Int J Epidemiol (2013) 3.23

Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project. Blood (2010) 3.21

Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: a pooled analysis from the International Lung Cancer Consortium. J Natl Cancer Inst (2010) 3.18

Factors associated with overall and attributable mortality in invasive aspergillosis. Clin Infect Dis (2008) 3.18

Lymph node ratio as an alternative to pN staging in node-positive breast cancer. J Clin Oncol (2009) 3.17

Inflammatory and metabolic biomarkers and risk of liver and biliary tract cancer. Hepatology (2014) 3.06

Consumption of vegetables and fruits and risk of breast cancer. JAMA (2005) 3.02

Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. J Clin Oncol (2013) 3.00

Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3. Nat Genet (2010) 2.96

Body size and breast cancer risk: findings from the European Prospective Investigation into Cancer And Nutrition (EPIC). Int J Cancer (2004) 2.96

Fruit, vegetables, and colorectal cancer risk: the European Prospective Investigation into Cancer and Nutrition. Am J Clin Nutr (2009) 2.93

Fruit and vegetable intake and the risk of stomach and oesophagus adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Int J Cancer (2006) 2.89

Cancer occurrence in Iran in 2002, an international perspective. Asian Pac J Cancer Prev (2005) 2.88

Standard cancer patient population for age standardising survival ratios. Eur J Cancer (2004) 2.87

Meat consumption and prospective weight change in participants of the EPIC-PANACEA study. Am J Clin Nutr (2010) 2.87

Evaluation of human papillomavirus antibodies and risk of subsequent head and neck cancer. J Clin Oncol (2013) 2.87

Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage. Am J Kidney Dis (2008) 2.85

Stage at diagnosis and colorectal cancer survival in six high-income countries: a population-based study of patients diagnosed during 2000-2007. Acta Oncol (2013) 2.84

Characteristics of Hodgkin's lymphoma after infectious mononucleosis. N Engl J Med (2003) 2.81

Women's perception of the benefits of mammography screening: population-based survey in four countries. Int J Epidemiol (2003) 2.79

Dietary fiber intake and risk of colorectal cancer: a pooled analysis of prospective cohort studies. JAMA (2005) 2.76

Balancing the harms and benefits of early detection of prostate cancer. Cancer (2010) 2.71

Pleural mesothelioma: epidemiological and public health issues. Report from the Second Italian Consensus Conference on Pleural Mesothelioma. Med Lav (2013) 2.71

Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations:a nested case-control study. BMJ (2010) 2.66

Thyroid cancer mortality and incidence: a global overview. Int J Cancer (2014) 2.63

Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors. Eur J Cancer (2005) 2.63

Hepatocellular carcinoma risk factors and disease burden in a European cohort: a nested case-control study. J Natl Cancer Inst (2011) 2.63

Smoking and risk for amyotrophic lateral sclerosis: analysis of the EPIC cohort. Ann Neurol (2009) 2.56

Prognostic relevance of gene amplifications and coamplifications in breast cancer. Cancer Res (2004) 2.55

Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst (2005) 2.53

Multiple ADH genes are associated with upper aerodigestive cancers. Nat Genet (2008) 2.53

Fatty acid composition of plasma phospholipids and risk of prostate cancer in a case-control analysis nested within the European Prospective Investigation into Cancer and Nutrition. Am J Clin Nutr (2008) 2.53

A national strategic change in treatment policy for rectal cancer--implementation of total mesorectal excision as routine treatment in Norway. A national audit. Dis Colon Rectum (2002) 2.53

Cancer burden in Africa and opportunities for prevention. Cancer (2012) 2.51

NORDCAN--a Nordic tool for cancer information, planning, quality control and research. Acta Oncol (2010) 2.48